OpenURL Connection Search

Select item for more details and to access through your institution.

Rare MYC-amplified Neuroblastoma With Large Cell Histology.
Published in:
Pediatric & Developmental Pathology, 2018, v. 21, n. 5, p. 461, doi. 10.1177/1093526617749670
By:
- Matsuno, Ryosuke;
- Gifford, Andrew J.;
- Fang, Junming;
- Warren, Mikako;
- Lukeis, Robyn E.;
- Trahair, Toby;
- Sugimoto, Tohru;
- Marachelian, Araz;
- Asgharzadeh, Shahab;
- Maris, John M.;
- Ikegaki, Naohiko;
- Shimada, Hiroyuki
Publication type:
Article
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38195-0
By:
- Berko, Esther R.;
- Witek, Gabriela M.;
- Matkar, Smita;
- Petrova, Zaritza O.;
- Wu, Megan A.;
- Smith, Courtney M.;
- Daniels, Alex;
- Kalna, Joshua;
- Kennedy, Annie;
- Gostuski, Ivan;
- Casey, Colleen;
- Krytska, Kateryna;
- Gerelus, Mark;
- Pavlick, Dean;
- Ghazarian, Susan;
- Park, Julie R.;
- Marachelian, Araz;
- Maris, John M.;
- Goldsmith, Kelly C.;
- Radhakrishnan, Ravi
Publication type:
Article
17230 Agreement between point-of-care intestinal ultrasound (POCUS) and magnetic resonance enterography for assessment of the terminal ileum through sigmoid colon in pediatric patients with inflammatory bowel diseases: A diagnostic cross-sectional study.
Published in:
2021
By:
- Chavannes, Mallory;
- Dillman, Jonathan R.;
- Marachelian, Araz;
- Polk, D Brent
Publication type:
Abstract
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
Published in:
2014
By:
- Kang, Min H.;
- Villablanca, Judith G.;
- Glade Bender, Julia L.;
- Matthay, Katherine K.;
- Groshen, Susan;
- Sposto, Richard;
- Czarnecki, Scarlett;
- Ames, Matthew M.;
- Patrick Reynolds, C.;
- Marachelian, Araz;
- Maurer, Barry J.
Publication type:
Case Study
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
Published in:
2016
By:
- Marachelian, Araz;
- Desai, Ami;
- Balis, Frank;
- Katzenstein, Howard;
- Qayed, Muna;
- Armstrong, Michael;
- Neville, Kathleen;
- Cohn, Susan;
- Bush, Mark;
- Gunawan, Rudy;
- Lim, Allison;
- Smith, Malcolm;
- Mary Smith, L.;
- Neville, Kathleen A;
- Cohn, Susan L;
- Lim, Allison Pecha;
- Smith, Malcolm A;
- Smith, L Mary
Publication type:
journal article
Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures.
Published in:
Radiation Research, 2022, v. 197, n. 2, p. 101, doi. 10.1667/RADE-20-00173.1
By:
- Evans, Angela C.;
- Setzkorn, Tim;
- Edmondson, David A.;
- Segelke, Haley;
- Wilson, Paul F.;
- Matthay, Katherine K.;
- Granger, M. Meaghan;
- Marachelian, Araz;
- Haas-Kogan, Daphne A.;
- DuBois, Steven G.;
- Coleman, Matthew A.
Publication type:
Article
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Published in:
British Journal of Cancer, 2024, v. 130, n. 5, p. 788, doi. 10.1038/s41416-023-02525-2
By:
- Hogarty, Michael D.;
- Ziegler, David S.;
- Franson, Andrea;
- Chi, Yueh-Yun;
- Tsao-Wei, Denice;
- Liu, Kangning;
- Vemu, Rohan;
- Gerner, Eugene W.;
- Bruckheimer, Elizabeth;
- Shamirian, Anasheh;
- Hasenauer, Beth;
- Balis, Frank M.;
- Groshen, Susan;
- Norris, Murray D.;
- Haber, Michelle;
- Park, Julie R.;
- Matthay, Katherine K.;
- Marachelian, Araz
Publication type:
Article
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I-MIBG in patients with relapsed/refractory neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2024, v. 71, n. 1, p. 1, doi. 10.1002/pbc.30743
By:
- Batra, Vandana;
- Gikandi, Ajami;
- Pawel, Bruce;
- Martinez, Daniel;
- Granger, M. Meaghan;
- Marachelian, Araz;
- Park, Julie R.;
- Maris, John M.;
- Vo, Kieuhoa T.;
- Matthay, Katherine K.;
- DuBois, Steven G.
Publication type:
Article
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus.
Published in:
Pediatric Blood & Cancer, 2023, v. 70, n. 5, p. 1, doi. 10.1002/pbc.30217
By:
- Nysom, Karsten;
- Morad, Andrea Gomez;
- Rafael, Margarida Simão;
- Zier, Judith;
- Marachelian, Araz;
- Watt, Tanya;
- Morgenstern, Daniel A.
Publication type:
Article
Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy.
Published in:
Pediatric Blood & Cancer, 2022, v. 69, n. 9, p. 1, doi. 10.1002/pbc.29719
By:
- Asgharzadeh, Shahab;
- Marachelian, Araz;
- Villablanca, Judith G.;
- Liu, Wei Yao;
- Kennedy, Rebekah;
- Sposto, Richard;
- Naranjo, Arlene;
- Tenney, Sheena;
- Yu, Alice L.;
- Ozkaynak, M. Fevzi;
- Sondel, Paul M.;
- Park, Julie R.;
- Seeger, Robert C.
Publication type:
Article
Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.
Published in:
2020
By:
- Duvalyan, Angela;
- Cha, Angela;
- Goodarzian, Fariba;
- Arkader, Alexandre;
- Villablanca, Judith G.;
- Marachelian, Araz
Publication type:
journal article
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Published in:
2018
By:
- Pinto, Navin;
- DuBois, Steven G.;
- Marachelian, Araz;
- Diede, Scott J.;
- Taraseviciute, Agne;
- Glade Bender, Julia L.;
- Tsao‐Wei, Denice;
- Groshen, Susan G.;
- Reid, Joel M.;
- Haas‐Kogan, Daphne A.;
- Reynolds, C. Patrick;
- Kang, Min H.;
- Irwin, Meredith S.;
- Macy, Margaret E.;
- Villablanca, Judith G.;
- Matthay, Katherine K.;
- Park, Julie R.;
- Tsao-Wei, Denice;
- Haas-Kogan, Daphne A
Publication type:
journal article
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
Published in:
2018
By:
- Villablanca, Judith G.;
- Ji, Lingyun;
- Shapira‐Lewinson, Adi;
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Hawkins, Randall A.;
- Pampaloni, Miguel;
- Lai, Hollie;
- Goodarzian, Fariba;
- Sposto, Richard;
- Park, Julie R.;
- Matthay, Katherine K.;
- Shapira-Lewinson, Adi
Publication type:
journal article
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Published in:
2016
By:
- Villablanca, Judith G.;
- Volchenboum, Samuel L.;
- Cho, Hwangeui;
- Kang, Min H.;
- Cohn, Susan L.;
- Anderson, Clarke P.;
- Marachelian, Araz;
- Groshen, Susan;
- Tsao‐Wei, Denice;
- Matthay, Katherine K.;
- Maris, John M.;
- Hasenauer, Charlotte E.;
- Czarnecki, Scarlett;
- Lai, Hollie;
- Goodarzian, Fariba;
- Shimada, Hiro;
- Reynolds, Charles Patrick;
- Tsao-Wei, Denice
Publication type:
journal article
Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
Published in:
2016
By:
- Trieu, Megan;
- DuBois, Steven G.;
- Pon, Elizabeth;
- Nardo, Lorenzo;
- Hawkins, Randall A.;
- Marachelian, Araz;
- Twist, Clare J.;
- Park, Julie R.;
- Matthay, Katherine K.
Publication type:
journal article
Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.
Published in:
Pediatric Blood & Cancer, 2013, v. 60, n. 12, p. 2012, doi. 10.1002/pbc.24665
By:
- Brown, Robert J.;
- Rahim, Hussein;
- Wong, Kenneth E.;
- Cooper, Robert M.;
- Marachelian, Araz;
- Butturini, Anna;
- Dhall, Girish;
- Finlay, Jonathan L.
Publication type:
Article
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
Published in:
2020
By:
- Mack, Jennifer W.;
- Cronin, Angel M.;
- Uno, Hajime;
- Shusterman, Suzanne;
- Twist, Clare J.;
- Bagatell, Rochelle;
- Rosenberg, Abby;
- Marachelian, Araz;
- Granger, M. Meaghan;
- Glade Bender, Julia;
- Baker, Justin N.;
- Park, Julie;
- Cohn, Susan L.;
- Levine, Alyssa;
- Taddei, Sarah;
- Diller, Lisa R.
Publication type:
journal article
High-dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Rescue in Children With Recurrent Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumors: The Impact of Prior Radiotherapy on Outcome.
Published in:
Cancer (0008543X), 2009, v. 115, n. 13, p. 2956, doi. 10.1002/cncr.24341
By:
- Butturini, Anna M.;
- Jacob, Mary;
- Aguajo, Jennifer;
- Vander-Walde, Noam A.;
- Villablanca, Judy;
- Jubran, Rima;
- Erdreich-Epstein, Anat;
- Marachelian, Araz;
- DhaIl, Girish;
- Finlay, Jonathan L.
Publication type:
Article
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.
Published in:
Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1801, doi. 10.1002/pbc.24643
By:
- Maurer, Barry J.;
- Kang, Min H.;
- Villablanca, Judith G.;
- Janeba, Jitka;
- Groshen, Susan;
- Matthay, Katherine K.;
- Sondel, Paul M.;
- Maris, John M.;
- Jackson, Hollie A.;
- Goodarzian, Fariba;
- Shimada, Hiroyuki;
- Czarnecki, Scarlett;
- Hasenauer, Beth;
- Reynolds, C. Patrick;
- Marachelian, Araz
Publication type:
Article
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Published in:
2012
By:
- Marachelian A;
- Shimada H;
- Sano H;
- Jackson H;
- Stein J;
- Sposto R;
- Matthay KK;
- Baker D;
- Villablanca JG;
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Sano, Hideki;
- Jackson, Hollie;
- Stein, James;
- Sposto, Richard;
- Matthay, Katherine K;
- Baker, David;
- Villablanca, Judith G
Publication type:
journal article
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2012, v. 58, n. 5, p. 675, doi. 10.1002/pbc.23250
By:
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Sano, Hideki;
- Jackson, Hollie;
- Stein, James;
- Sposto, Richard;
- Matthay, Katherine K.;
- Baker, David;
- Villablanca, Judith G.
Publication type:
Article
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.
Published in:
Pediatric Blood & Cancer, 2011, v. 57, n. 2, p. 275, doi. 10.1002/pbc.22821
By:
- Russell, Heidi V.;
- Groshen, Susan G.;
- Ara, Tasnim;
- DeClerck, Yves A.;
- Hawkins, Randy;
- Jackson, Hollie A.;
- Daldrup-Link, Heike E.;
- Marachelian, Araz;
- Skerjanec, Andrej;
- Park, Julie R.;
- Katzenstein, Howard;
- Matthay, Katherine K.;
- Blaney, Susan M.;
- Villablanca, Judith G.
Publication type:
Article
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Published in:
Pediatric Blood & Cancer, 2010, v. 55, n. 1, p. 42, doi. 10.1002/pbc.22468
By:
- Khatua, Soumen;
- Dhall, Girish;
- O'Neil, Sharon;
- Jubran, Rima;
- Villablanca, Judith G.;
- Marachelian, Araz;
- Nastia, Arti;
- Lavey, Robert;
- Olch, Arthur J.;
- Gonzalez, Ignacio;
- Gilles, Floyd;
- Nelson, Marvin;
- Panigrahy, Ashok;
- McComb, Gordon;
- Krieger, Mark;
- Fan, Jing;
- Sposto, Richard;
- Finlay, Jonathan L.
Publication type:
Article
Successful radiation therapy for supratentorial primitive neuroectodermal tumor and epidermolysis bullosa simplex.
Published in:
Pediatric Blood & Cancer, 2010, v. 54, n. 1, p. 170, doi. 10.1002/pbc.22281
By:
- Bavishi, Sejal;
- Wong, Kenneth;
- Delgardo, Thamani;
- Marachelian, Araz;
- Khatua, Soumen
Publication type:
Article
Predictors of outcome in children with Langerhans cell histiocytosis.
Published in:
Pediatric Blood & Cancer, 2005, v. 45, n. 1, p. 37, doi. 10.1002/pbc.20364
By:
- Jubran, Rima F.;
- Marachelian, Araz;
- Dorey, Frederick;
- Malogolowkin, Marcio
Publication type:
Article
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi‐site longitudinal survey study.
Published in:
Cancer (0008543X), 2024, v. 130, n. 7, p. 1101, doi. 10.1002/cncr.35149
By:
- Kaye, Erica C.;
- Smith, Jesse;
- Zhou, Yiwang;
- Bagatell, Rochelle;
- Baker, Justin N.;
- Cohn, Susan L.;
- Diller, Lisa R.;
- Glade Bender, Julia L.;
- Granger, M. Meaghan;
- Marachelian, Araz;
- Park, Julie R.;
- Rosenberg, Abby R.;
- Shusterman, Suzanne;
- Twist, Clare J.;
- Mack, Jennifer W.
Publication type:
Article
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46968-2
By:
- Lascano, Danny;
- Zobel, Michael J.;
- Lee, William G.;
- Chen, Stephanie Y.;
- Zamora, Abigail;
- Asuelime, Grace E.;
- Choi, So Yung;
- Chronopoulos, Antonios;
- Asgharzadeh, Shahab;
- Marachelian, Araz;
- Park, Jinseok;
- Sheard, Michael A.;
- Kim, Eugene S.
Publication type:
Article

Found: 27

Rare MYC-amplified Neuroblastoma With Large Cell Histology.

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.

17230 Agreement between point-of-care intestinal ultrasound (POCUS) and magnetic resonance enterography for assessment of the terminal ileum through sigmoid colon in pediatric patients with inflammatory bowel diseases: A diagnostic cross-sectional study.

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.

Peripheral Blood Transcript Signatures after Internal <sup>131</sup>I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal <sup>131</sup>I Exposures.

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to <sup>131</sup>I-MIBG in patients with relapsed/refractory neuroblastoma.

Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus.

Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy.

Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).

Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.

Unrealistic parental expectations for cure in poor-prognosis childhood cancer.

High-dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Rescue in Children With Recurrent Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumors: The Impact of Prior Radiotherapy on Outcome.

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.

Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.

Successful radiation therapy for supratentorial primitive neuroectodermal tumor and epidermolysis bullosa simplex.

Predictors of outcome in children with Langerhans cell histiocytosis.

Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi‐site longitudinal survey study.

Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.